Nonsteroidal Anti‐Inflammatory Use and LRRK2 Parkinson's Disease Penetrance
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nonsteroidal
Anti‐Inflammatory
Use and
LRRK2
Parkinson's Disease Penetrance
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-07-14
DOI
10.1002/mds.28189
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LRRK2 links genetic and sporadic Parkinson's disease
- (2019) Jillian H. Kluss et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Higher urate in LRRK2 mutation carriers resistant to Parkinson disease
- (2019) Rachit Bakshi et al. ANNALS OF NEUROLOGY
- Personality and Parkinson's disease: A meta-analysis
- (2018) Gabriella Santangelo et al. PARKINSONISM & RELATED DISORDERS
- Nonsteroidal anti-inflammatory drugs use and risk of Parkinson disease
- (2018) Li Ren et al. MEDICINE
- Non-steroidal anti-inflammatory drugs and risk of Parkinson’s disease in the elderly population: a meta-analysis
- (2018) Tahmina Nasrin Poly et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Genotype-phenotype relations for the Parkinson's disease genes SNCA, LRRK2, VPS35: MDSGene systematic review
- (2018) Joanne Trinh et al. MOVEMENT DISORDERS
- Inflammatory profile discriminates clinical subtypes inLRRK2-associated Parkinson's disease
- (2017) K. Brockmann et al. EUROPEAN JOURNAL OF NEUROLOGY
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- The epidemiology of Parkinson's disease: risk factors and prevention
- (2016) Alberto Ascherio et al. LANCET NEUROLOGY
- Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers
- (2016) Nicolas Dzamko et al. MOVEMENT DISORDERS
- Motor and nonmotor heterogeneity of LRRK2 -related and idiopathic Parkinson's disease
- (2016) Connie Marras et al. MOVEMENT DISORDERS
- Nrf2 mitigates LRRK2- and α-synuclein–induced neurodegeneration by modulating proteostasis
- (2016) Gaia Skibinski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antioxidants inhibit neuronal toxicity in Parkinson's disease-linked LRRK2
- (2016) Dario C. Angeles et al. Annals of Clinical and Translational Neurology
- Neuroprotective effects of urate are mediated by augmenting astrocytic glutathione synthesis and release
- (2015) Rachit Bakshi et al. NEUROBIOLOGY OF DISEASE
- The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson’s disease
- (2015) J. Schapansky et al. NEUROSCIENCE
- The disease intersection of susceptibility and exposure: Chemical exposures and neurodegenerative disease risk
- (2014) Caroline M. Tanner et al. Alzheimers & Dementia
- Late stages of hematopoiesis and B cell lymphopoiesis are regulated by α-synuclein, a key player in Parkinson's disease
- (2014) Wenbin Xiao et al. IMMUNOBIOLOGY
- Environmental Toxins and Parkinson's Disease
- (2013) Samuel M. Goldman Annual Review of Pharmacology and Toxicology
- The role of inflammation in sporadic and familial Parkinson’s disease
- (2013) Michela Deleidi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database
- (2012) Christina M. Lill et al. PLoS Genetics
- Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures
- (2011) Mansoureh Hakimi et al. JOURNAL OF NEURAL TRANSMISSION
- Pain in Parkinson's disease
- (2011) Ainhi D. Ha et al. MOVEMENT DISORDERS
- Use of ibuprofen and risk of Parkinson disease
- (2011) X. Gao et al. NEUROLOGY
- Regulation of LRRK2 Expression Points to a Functional Role in Human Monocyte Maturation
- (2011) Jonathan Thévenet et al. PLoS One
- MultipleLRRK2variants modulate risk of Parkinson disease: a Chinese multicenter study
- (2010) Eng-King Tan et al. HUMAN MUTATION
- LOW DISEASE RISK IN RELATIVES OF NORTH AFRICAN LRRK2 PARKINSON DISEASE PATIENTS
- (2010) A. R. Troiano et al. NEUROLOGY
- Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis
- (2010) J. J. Gagne et al. NEUROLOGY
- Neuroinflammation in Parkinson's disease: a target for neuroprotection?
- (2009) Etienne C Hirsch et al. LANCET NEUROLOGY
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- (2008) Daniel G Healy et al. LANCET NEUROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started